Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TFPI | P10646 | 1/20 | 0.65 |
| ▸ | GLP1R | P43220 | 4/20 | 0.60 |
| ▸ | VIPR1 | P32241 | 3/20 | 0.59 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.58 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.58 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.58 |
| ▸ | VIPR2 | P41587 | 3/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29373287 | 0.94 | TFPI (0.66) | TFPIGLP1RVIPR1OPRM1OPRD1 | |
| SCHEMBL29679928 | 0.94 | TFPI (0.60) | TFPIGLP1RVIPR1OPRM1OPRD1 | |
| SCHEMBL29373682 | 0.93 | TFPI (0.68) | TFPIGLP1RVIPR1OPRM1OPRD1 | |
| SCHEMBL31182935 | 0.93 | TFPI (0.62) | TFPIGLP1RVIPR1 | |
| SCHEMBL29365490 | 0.93 | TFPI (0.62) | TFPIGLP1RVIPR1OPRM1OPRD1 | |
| SCHEMBL29376362 | 0.92 | TFPI (0.66) | TFPIGLP1RVIPR1 | |
| SCHEMBL30721553 | 0.92 | TFPI (0.66) | TFPIGLP1RVIPR1 | |
| SCHEMBL30432094 | 0.92 | VIPR1 (0.61) | TFPIGLP1RVIPR1VIPR2 | |
| SCHEMBL30120636 | 0.92 | TFPI (0.66) | TFPIGLP1RVIPR1 | |
| SCHEMBL31182918 | 0.92 | TFPI (0.64) | TFPIGLP1RVIPR1OPRM1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4630447-A2 | ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF | Abwiz Bio, Inc. (US) | 2025-10-15 | — | — | EP | disclosed |
| WO-2024124241-A2 | ANTIBODIES OR FRAGMENTS THEREOF FOR SARS-COV-2 AND VARIANTS THEREOF | ABWIZ BIO, INC. (US) | 2024-06-13 | — | — | WO | disclosed |